News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nouveau Life Pharmaceuticals (NOUV) Releases Vitamins A&D to Promote Strong Bones and Healthy Eyes


8/2/2012 1:38:12 PM

FORT LAUDERDALE, Fla., Aug. 2, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals Inc. (OTC Pink: NOUV), a provider of quality all-natural dietary supplements, announced today the release of the newest product in the Company's New Life Naturals product line: For Your Health Vitamins A&D.

Vitamins A&D promote strong bones and healthy eyes. Vitamin A is recognized for its roles in the body including vision, growth, reproduction, the immune system, the development of primary body tissue, bones, blood cellular components and the brain. Vitamin D is a nutrient that is needed for health and to maintain strong bones. A Vitamin D deficiency may lead to brittle bones. Vitamin D is also involved in muscle movement and nerve function, and the immune system needs Vitamin D to fight off invading bacteria and viruses.

For Your Health Vitamins A&D was developed by Nouveau Life as part of the Company's focus on health concerns for Baby Boomers and aging adults. The supplement is currently available for purchase at the Nouveau Life online store at www.nlpnaturals.com and will soon be available on Amazon. The recommended dose is one soft gelatin capsule daily. Every bottle contains 100 softgels, each containing 10,000 UI of Vitamin A and 400 UI of Vitamin D. The supplement retails for $9.99.

About Nouveau Life Pharmaceuticals

The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.

CONTACT:
Nouveau Life Pharmaceuticals, Inc. - 954-903-2993
SOURCE Nouveau Life Pharmaceuticals, Inc.

SOURCE Nouveau Life Pharmaceuticals, Inc.


Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES